[1]
“BIOTECHNOLOGY-DRIVEN VACCINE MANUFACTURING AND QUALITY CONTROL FOR CARDIOVASCULAR PROTECTION: CHALLENGES AND PUBLIC HEALTH OPPORTUNITIES”, Biosci. Insights., vol. 3, no. 02, pp. 208–223, Aug. 2026, Accessed: Nov. 09, 2026. [Online]. Available: https://biosciinsights.com/index.php/BI/article/view/69